At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly automated world? For Mike Guarino, CEO of EVERSANA INTOUCH, the answer lies not in replacement, but in amplification. He describes today’s environment as a “point of convergence,” where technology, talent, and strategy must operate in sync—unlocking new levels of creative and commercial impact.

This convergence is reshaping the agency model itself. Rather than delivering discrete outputs, organizations are being asked to drive meaningful outcomes across the entire commercialization continuum. EVERSANA’s AI-powered platform—developed in partnership with Google—reflects this shift, enabling both enterprise-scale adoption and more incremental integration into existing workflows. As client demand accelerates, conversations are quickly expanding beyond efficiency to include compliance, governance, and long-term investment strategy.

Yet even as data and AI become more pervasive, Guarino argues that differentiation will hinge on something more enduring: the ability to translate insight into story. Data may inform, but it is storytelling that creates resonance. In that sense, the rise of AI does not diminish creativity—it raises the bar for it. The organizations that succeed will be those that can combine deeper data access with sharper critical thinking, using technology not just to optimize performance, but to connect more meaningfully with the human experience at the center of healthcare.

News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky

Our books now available worldwide!

Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]